Investor Tim Seymour talks about the Apple-Trump deal and other trade headlines.
Eli Lilly earnings are coming Thursday. Here’s what top analysts expect
Wall Street is optimistic heading into Eli Lilly’s second-quarter earnings report.
What is wrong with chip stocks this earnings season?
Kristina Partsinevelos breaks down the latest action in AMD and chip stocks.
Morgan Stanley’s picks to surprise on earnings rest of the reporting season
Analyst Ronald Ho provided a list of more than two dozen stocks expected to report earnings between Aug. 5 and Sept. 2 that are rated overweight by the firm.
Evercore ISI sees big gains for this under-the-radar ‘AI pure play’
The firm’s new price target suggests shares of Astera Labs could gain 58.6% from its latest close.
Lowe’s trades at attractive levels. Using options to capture potential gains ahead
Options trader Tony Zhang goes breaks down this bullish Lowe’s trade heading into earnings.
Bank of America nearly doubles MP Materials price target, raises earnings estimates ahead of Q2 results
MP will report second-quarter financial results on Thursday after striking an unprecedented deal with the Pentagon last month.
JPMorgan sees shares of this 10-minute oil change company rallying 30%
Shares have gained ore than 7% so far in 2025.
RBC sees nearly 30% upside for this medical tech stock as headwinds abate
The bank pointed to recent M&A success as a catalyst for the stock.
Citizens downgrades Snap after second-quarter revenue miss sparks sell-off
As reasons for the Snap downgrade, Citizens pointed to ongoing leadership changes and increasing competition.